BTI
BCYC

Blue Trust Inc’s Bicycle Therapeutics BCYC Stock Holding History

Blue Trust Inc’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11
Closed -$85 – 2548
2025
Q3 		$85 Hold
11
– – ﹤0.01% 2541
2025
Q2 		$76 Hold
11
– – ﹤0.01% 2412
2025
Q1 		$93 Hold
11
– – ﹤0.01% 2447
2024
Q4 		$154 Sell
11
-524
-98% -$11.2K ﹤0.01% 2391
2024
Q3 		$10.8K Buy
535
+212
+66% +$4.89K ﹤0.01% 2167
2024
Q2 		$8.04K Buy
+323
New +$7.3K ﹤0.01% 2017
2024
Q1 		– Sell
-138
Closed -$3K – 2211
2023
Q4 		$3K Buy
+138
New +$2.28K ﹤0.01% 1984
2023
Q1 		– Sell
-20
Closed – – 2305
2022
Q4 		$0 Buy
+20
New +$537 ﹤0.01% 2234

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
GP
GSK plc London $599M AUM
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Trust Inc's BCYC Position: Q4 2025 in Review

Blue Trust Inc sold out of Bicycle Therapeutics (BCYC) in Q4 2025, closing a stake of 11 shares — an estimated $85 sold.

Blue Trust Inc first reported a position in BCYC in Q4 2022 and held it in 8 quarters. The position peaked at $10.8K in Q3 2024. 109 funds tracked by Wall St. Rank hold BCYC as of Q4 2025.

  • Blue Trust Inc reported no remaining Bicycle Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Blue Trust Inc sold 11 Bicycle Therapeutics shares in Q4 2025, an estimated $85.
  • Blue Trust Inc first reported a position in Bicycle Therapeutics in Q4 2022 and held it in 8 quarters.
  • Blue Trust Inc's Bicycle Therapeutics position peaked at $10.8K in Q3 2024.
  • 109 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2025.

Based on Blue Trust Inc's 13F filing for Q4 2025, filed 16 Jan 2026.